Evidence map›Paper›PMID 40269772›Full record

ArticleBMC infectious diseases2025

Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: aegean experience.

Ilkay Akbulut, Zeynep Sedef Varol, Veysel Akca, Basak Gol Serin, Emel Erogul, Ilker Odemiş, Seniha Senbayrak, Sabri Atalay

Abstract readMulticenter Study
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ilkay AkbulutDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University Tepecik Training and Research Hospital, Yenisehir, Gaziler Cd No: 468, 35020 Konak, Izmir, Türkiye. ilkayakbulutdr@gmail.com.
Zeynep Sedef VarolDepartment of Public Health, Izmir Health Directorate, Izmir, Türkiye.
Veysel AkcaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Türkiye.
Basak Gol SerinDepartment of Infectious Diseases and Clinical Microbiology, Balikesir Provincial Health Directorate Atatürk City Hospital, Balikesir, Türkiye.
Emel ErogulDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University Tepecik Training and Research Hospital, Yenisehir, Gaziler Cd No: 468, 35020 Konak, Izmir, Türkiye.
Ilker OdemişDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University Tepecik Training and Research Hospital, Yenisehir, Gaziler Cd No: 468, 35020 Konak, Izmir, Türkiye.
Seniha SenbayrakDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Istanbul, Türkiye.
Sabri AtalayDepartment of Infectious Diseases and Clinical Microbiology, Health Sciences University Tepecik Training and Research Hospital, Yenisehir, Gaziler Cd No: 468, 35020 Konak, Izmir, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION/

objectiveThis Turkish study aimed to investigate the factors that contribute to the failure of virological suppression in people with human immunodeficiency virus (HIV) receiving antiretroviral therapy (ART). The factors evaluated were sociodemographic characteristics, opportunistic infections, polypharmacy, comorbidities, and the ART regimen used. The purpose of this investigation was to obtain important insights that can be utilized to improve treatment strategies at both individual and public health levels.

methodsThis multicenter retrospective case-control study compared data from 263 patients with suppressed viremia with 125 with unsuppressed viremia, all treated at one of three hospitals in the Aegean region of Turkiye. Sociodemographic and clinical characteristics and ART regimen details were compared between the two groups. Logistic regression analysis was used to identify the predictors of virological failure.

resultsPatients with unsuppressed viremia were significantly more likely to be older, have lower educational levels, and reside in large cities. Our logistic regression analysis showed that each additional month since HIV diagnosis increased the risk of virological failure by 2%. Moreover, each 1% increase in nadir CD4 + T-cells reduced the risk of virological failure by 4%. Opportunistic infections increased the risk of virological failure by 3.25 times. Interestingly, virological failure was 6.5 times more likely in patients who did not suffer ART side effects.

conclusionsThis study identified the sociodemographic, clinical, and treatment-related factors that contribute to virological failure in people with HIV in Turkiye. This can be utilized to develop individualized treatment strategies and improve virological control and clinical outcomes.

Indexed as

Anti-HIV AgentsHIV InfectionsViremiaAdultCase-Control StudiesCD4 Lymphocyte CountFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTreatment FailureTurkeyViral LoadAnti-HIV AgentsAntiretroviral therapyHuman immunodeficiency virusTurkiyeUnsuppressed viremia

Identifiers

PMID40269772
PMCPMC12020084

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.